CD2-associated protein regulates plasmacytoid dendritic cell migration, but is dispensable for their development and cytokine production

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 5933-5940

  Srivatsan, Subhashini ^a   Swiecki, Melissa ^a   Otero, Karel ^a,b   Cella, Marina ^a   Shaw, Andrey S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ASSOCIATED PROTEIN; INTERFERON;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HOMING; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPH NODE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION; WILD TYPE;

EID: 84890424736     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300454     Document Type: Article

References (52)

1. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5: 919-923.
2. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
3. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, F. Brière, and G. Trinchieri. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2: 1144-1150.
4. Nakano, H., M. Yanagita, and M. D. Gunn. 2001. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194: 1171-1178.
5. Björck, P. 2001. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98: 3520-3526.
6. Krug, A., R. Uppaluri, F. Facchetti, B. G. Dorner, K. C. Sheehan, R. D. Schreiber, M. Cella, and M. Colonna. 2002. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 169: 6079-6083.
7. Penna, G., M. Vulcano, A. Roncari, F. Facchetti, S. Sozzani, and L. Adorini. 2002. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 169: 6673-6676.
8. Biron, C. A. 2001. Interferons alpha and beta as immune regulators - a new look. Immunity 14: 661-664.
9. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
10. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294: 1540-1543.
11. Santini, S. M., T. Di Pucchio, C. Lapenta, S. Parlato, M. Logozzi, and F. Belardelli. 2002. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 22: 1071-1080.
12. Le Bon, A., N. Etchart, C. Rossmann, M. Ashton, S. Hou, D. Gewert, P. Borrow, and D. F. Tough. 2003. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4: 1009-1015.
13. Young, L. J., N. S. Wilson, P. Schnorrer, A. Proietto, T. ten Broeke, Y. Matsuki, A. M. Mount, G. T. Belz, M. O'Keeffe, M. Ohmura-Hoshino, et al. 2008. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9: 1244-1252.
14. Di Pucchio, T., B. Chatterjee, A. Smed-Sörensen, S. Clayton, A. Palazzo, M. Montes, Y. Xue, I. Mellman, J. Banchereau, and J. E. Connolly. 2008. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9: 551-557.
15. Farkas, L., K. Beiske, F. Lund-Johansen, P. Brandtzaeg, and F. L. Jahnsen. 2001. Plasmacytoid dendritic cells (natural interferon-alpha/beta- producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159: 237-243.
16. Albanesi, C., C. Scarponi, S. Pallotta, R. Daniele, D. Bosisio, S. Madonna, P. Fortugno, S. Gonzalvo-Feo, J. D. Franssen, M. Parmentier, et al. 2009. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206: 249-258.
17. Albanesi, C., C. Scarponi, D. Bosisio, S. Sozzani, and G. Girolomoni. 2010. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 43: 215-219.
18. Facchetti, F., C. de Wolf-Peeters, J. J. van den Oord, R. de Vos, and V. J. Desmet. 1989. Plasmacytoid monocytes (so-called plasmacytoid T-cells) in Kikuchi's lymphadenitis: an immunohistologic study. Am. J. Clin. Pathol. 92: 42-50.
19. Fitzgerald-Bocarsly, P., J. Dai, and S. Singh. 2008. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 19: 3-19.
20. Dzionek, A., Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Günther, I. Johnston, A. Lanzavecchia, T. Nagasaka, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194: 1823-1834.
21. Urosevic, M., C. Conrad, J. Kamarashev, K. Asagoe, A. Cozzio, G. Burg, and R. Dummer. 2005. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum. Pathol. 36: 1020-1024.
22. Jaye, D. L., C. M. Geigerman, M. Herling, K. Eastburn, E. K. Waller, and D. Jones. 2006. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod. Pathol. 19: 1555-1562.
23. Chaperot, L., I. Perrot, M. C. Jacob, D. Blanchard, V. Salaun, V. Deneys, S. Lebecque, F. Brière, J. C. Bensa, and J. Plumas. 2004. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur. J. Immunol. 34: 418-426.
24. Marafioti, T., J. C. Paterson, E. Ballabio, K. K. Reichard, S. Tedoldi, K. Hollowood, M. Dictor, M. L. Hansmann, S. A. Pileri, M. J. Dyer, et al. 2008. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 111: 3778-3792.
25. Dustin, M. L., M. W. Olszowy, A. D. Holdorf, J. Li, S. Bromley, N. Desai, P. Widder, F. Rosenberger, P. A. van der Merwe, P. M. Allen, and A. S. Shaw. 1998. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94: 667-677.
26. Soubeyran, P., K. Kowanetz, I. Szymkiewicz, W. Y. Langdon, and I. Dikic. 2002. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416: 183-187.
27. Szymkiewicz, I., K. Kowanetz, P. Soubeyran, A. Dinarina, S. Lipkowitz, and I. Dikic. 2002. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J. Biol. Chem. 277: 39666-39672.
28. Haglund, K., N. Shimokawa, I. Szymkiewicz, and I. Dikic. 2002. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc. Natl. Acad. Sci. USA 99: 12191-12196.
29. Molfetta, R., F. Belleudi, G. Peruzzi, S. Morrone, L. Leone, I. Dikic, M. Piccoli, L. Frati, M. R. Torrisi, A. Santoni, and R. Paolini. 2005. CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function. J. Immunol. 175: 4208-4216.
30. Cormont, M., I. Metón, M. Mari, P. Monzo, F. Keslair, C. Gaskin, T. E. McGraw, and Y. Le Marchand-Brustel. 2003. CD2AP/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl. Traffic 4: 97-112.
31. Kirsch, K. H., M. M. Georgescu, S. Ishimaru, and H. Hanafusa. 1999. CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc. Natl. Acad. Sci. USA 96: 6211-6216.
32. Hutchings, N. J., N. Clarkson, R. Chalkley, A. N. Barclay, and M. H. Brown. 2003. Linking the T cell surface protein CD2 to the actin-capping protein CAPZ via CMS and CIN85. J. Biol. Chem. 278: 22396-22403.
33. Bruck, S., T. B. Huber, R. J. Ingham, K. Kim, H. Niederstrasser, P. M. Allen, T. Pawson, J. A. Cooper, and A. S. Shaw. 2006. Identification of a novel inhibitory actin-capping protein binding motif in CD2-associated protein. J. Biol. Chem. 281: 19196-19203.
34. Zhao, J., S. Bruck, S. Cemerski, L. Zhang, B. Butler, A. Dani, J. A. Cooper, and A. S. Shaw. 2013. CD2AP links cortactin and capping protein at the cell periphery to facilitate formation of lamellipodia. Mol. Cell. Biol. 33: 38-47.
35. Shih, N. Y., J. Li, V. Karpitskii, A. Nguyen, M. L. Dustin, O. Kanagawa, J. H. Miner, and A. S. Shaw. 1999. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286: 312-315.
36. Lefrancois, L., and N. Lycke. 2001. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. Curr. Protoc. Immunol. Chapter 3: Unit 3.19.
37. Swiecki, M., S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna. 2010. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33: 955-966.
38. Bao, M., S. Hanabuchi, V. Facchinetti, Q. Du, L. Bover, J. Plumas, L. Chaperot, W. Cao, J. Qin, S. C. Sun, and Y. J. Liu. 2012. CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl. J. Immunol. 189: 786-792.
39. Ghosh, H. S., B. Cisse, A. Bunin, K. L. Lewis, and B. Reizis. 2010. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33: 905-916.
40. Kim, J. M., H. Wu, G. Green, C. A. Winkler, J. B. Kopp, J. H. Miner, E. R. Unanue, and A. S. Shaw. 2003. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298-1300.
41. Blasius, A. L., E. Giurisato, M. Cella, R. D. Schreiber, A. S. Shaw, and M. Colonna. 2006. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177: 3260-3265.
42. Blasius, A., W. Vermi, A. Krug, F. Facchetti, M. Cella, and M. Colonna. 2004. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood 103: 4201-4206.
43. Takagi, H., T. Fukaya, K. Eizumi, Y. Sato, K. Sato, A. Shibazaki, H. Otsuka, A. Hijikata, T. Watanabe, O. Ohara, et al. 2011. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35: 958-971.
44. Yaddanapudi, S., M. M. Altintas, A. D. Kistler, I. Fernandez, C. C. Möller, C. Wei, V. Peev, J. B. Flesche, A. L. Forst, J. Li, et al. 2011. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J. Clin. Invest. 121: 3965-3980.
45. Welsch, T., N. Endlich, G. Gökce, E. Doroshenko, J. C. Simpson, W. Kriz, A. S. Shaw, and K. Endlich. 2005. Association of CD2AP with dynamic actin on vesicles in podocytes. Am. J. Physiol. Renal Physiol. 289: F1134-F1143.
46. Vicente-Manzanares, M., and A. R. Horwitz. 2011. Cell migration: an overview. Methods Mol. Biol. 769: 1-24.
47. Diacovo, T. G., A. L. Blasius, T. W. Mak, M. Cella, and M. Colonna. 2005. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J. Exp. Med. 202: 687-696.
48. Asselin-Paturel, C., G. Brizard, J. J. Pin, F. Brière, and G. Trinchieri. 2003. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171: 6466-6477.
49. Welsch, T., N. Endlich, W. Kriz, and K. Endlich. 2001. CD2AP and p130Cas localize to different F-actin structures in podocytes. Am. J. Physiol. Renal Physiol. 281: F769-F777.
50. Schmidt, M. H., B. Chen, L. M. Randazzo, and O. Bogler. 2003. SETA/CIN85/ Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. J. Cell Sci. 116: 2845-2855.
51. Gaidos, G., S. Soni, D. J. Oswald, P. A. Toselli, and K. H. Kirsch. 2007. Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation. J. Cell Sci. 120: 2366-2377.
52. Lehtonen, S., F. Zhao, and E. Lehtonen. 2002. CD2-associated protein directly interacts with the actin cytoskeleton. Am. J. Physiol. Renal Physiol. 283: F734- F743.